Omeros (OMER) Interest Expenses (2010 - 2026)
Omeros (OMER) reported Interest Expenses of $5.9 million for Q1 2026, down 42.32% on a YoY basis from $10.2 million in Q1 2025, and down 32.45% sequentially from $8.7 million in Q4 2025.
Omeros (OMER) Interest Expenses (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Interest Expenses data on file, last reported at $5.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 42.32% year-over-year to $5.9 million; the trailing twelve-month figure through Mar 2026 stood at $49.0 million (down 5.45% YoY), and the FY2025 full-year result was $182.3 million, up 226.98% from the prior year.
- Interest Expenses fell to $5.9 million in Q1 2026, from $8.7 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $24.2 million in Q4 2024 to a low of -$11.9 million in Q4 2022.
- A 5-year average of $9.2 million and a median of $7.9 million in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses slumped 196.31% in 2022 and jumped 277.01% in 2023, its largest moves.
- Tracing OMER's Interest Expenses over 5 years: stood at -$11.9 million in 2022, then jumped by 277.01% to $21.1 million in 2023, then advanced by 14.74% to $24.2 million in 2024, then plunged by 63.89% to $8.7 million in 2025, then plunged by 32.45% to $5.9 million in 2026.
- Business Quant data shows OMER's Interest Expenses at $5.9 million in Q1 2026, $8.7 million in Q4 2025, and $21.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | 5.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.89 Mn |
| Mar 31, 2026 | 5.89 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Dec 31, 2025 | 8.73 Mn |
| Sep 30, 2025 | 21.65 Mn |
| Sep 30, 2025 | 21.65 Mn |
| Jun 30, 2025 | 12.87 Mn |
| Jun 30, 2025 | 12.87 Mn |
| Mar 31, 2025 | 10.22 Mn |
| Mar 31, 2025 | 10.22 Mn |
| Dec 31, 2024 | 24.17 Mn |
| Dec 31, 2024 | 24.17 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Mar 31, 2024 | 8.23 Mn |
| Dec 31, 2023 | 21.06 Mn |
| Dec 31, 2023 | 21.06 Mn |